Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Payables (2021 - 2025)

Historic Payables for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to $150734.0.

  • Cardio Diagnostics Holdings' Payables rose 10149.45% to $150734.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $150734.0, marking a year-over-year increase of 10149.45%. This contributed to the annual value of $87661.0 for FY2024, which is 6395.71% down from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Payables stood at $150734.0 for Q3 2025, which was up 10149.45% from $48724.0 recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Payables registered a high of $1.6 million during Q3 2023, and its lowest value of $33885.0 during Q4 2021.
  • Its 5-year average for Payables is $487486.4, with a median of $150734.0 in 2025.
  • Its Payables has fluctuated over the past 5 years, first surged by 314254.98% in 2022, then plummeted by 9667.56% in 2024.
  • Cardio Diagnostics Holdings' Payables (Quarter) stood at $33885.0 in 2021, then surged by 3142.55% to $1.1 million in 2022, then tumbled by 77.86% to $243213.0 in 2023, then plummeted by 63.96% to $87661.0 in 2024, then surged by 71.95% to $150734.0 in 2025.
  • Its last three reported values are $150734.0 in Q3 2025, $48724.0 for Q2 2025, and $108181.0 during Q1 2025.